View source for Drug-drug, drug-allergy interaction checks (MU2)

==Overview==

==MU Requirements==
===Per ONC===
:Taken from ONC Final Rule:[[File:2014_Edition_Cert_Federal_Register.pdf]]
<pre>
(2) Drug-drug, drug-allergy interaction checks. (i) Interventions. Before a medication order is
completed and acted upon during computerized provider order entry (CPOE), interventions must
automatically and electronically indicate to a user drug-drug and drug-allergy contraindications
based on a patient’s medication list and medication allergy list.
(ii) Adjustments. (A) Enable the severity level of interventions provided for drug-drug
interaction checks to be adjusted.
(B) Limit the ability to adjust severity levels to an identified set of users or available as a
system administrative function.
</pre>
===Per ONC/NIST Final Test Methods===
:See here: http://www.healthit.gov/policy-researchers-implementers/2014-edition-final-test-method

==Status==
*This is (and was) handled by the NewCrop Interface.  It may be possible with Stage II to certify wit multiple eRX interfaces if the others that are in use can be "merged" or made installable.  Specifically DrFirst and Relay Health.
*According to Tony during MU2 conference call 10/12/2013, this is pending ongoing NewCrop development. [[User:Bradymiller|Bradymiller]] 19:55, 12 October 2013 (UTC)
*Also should be supported by ZH Healthcare module: http://sourceforge.net/p/zhopenemr/wiki/ePrescription/

==Proposal==

==Owner==
:NewCrop

==Links==
:*[[OpenEMR Certification Stage II Meaningful Use|OpenEMR Certification Stage II Meaningful Use Main Project Page]]
:*[[Drug Decision Support|Drug Decision Support wiki page for stage I certification]]


[[Category:Certification]][[Category:Certification Stage II]]